Psoriasis
1,130
76
109
784
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
316 trials with published results (28%)
Research Maturity
784 completed trials (69% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.2%
59 terminated out of 1130 trials
93.0%
+6.5% vs benchmark
28%
311 trials in Phase 3/4
40%
316 of 784 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 784 completed trials
Clinical Trials (1130)
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania
Effects of Different Secukinumab Maintenance Regimens on Long-Term Outcomes in Patients With Psoriasis
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features
A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients
The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
Trial of HSK44459 Cream for the Management Plaque Psoriasis
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)
Psoriasis Longitudinal Assessment and Registry
Pentoxifylline Add-On Therapy for Mild-to-Moderate Plaque Psoriasis
A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting
Psorcast Mobile Study
Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis
Metabolic Profiling of Immune Responses in Immune-mediated Diseases